Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP331116.RAVtPnbjwttz2fgfB3VnEtie_kRl6Jj8o7S-LkB6Wu41A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP331116.RAVtPnbjwttz2fgfB3VnEtie_kRl6Jj8o7S-LkB6Wu41A130_assertion type Assertion NP331116.RAVtPnbjwttz2fgfB3VnEtie_kRl6Jj8o7S-LkB6Wu41A130_head.
- NP331116.RAVtPnbjwttz2fgfB3VnEtie_kRl6Jj8o7S-LkB6Wu41A130_assertion wasGeneratedBy ECO_0000203 NP331116.RAVtPnbjwttz2fgfB3VnEtie_kRl6Jj8o7S-LkB6Wu41A130_provenance.
- NP331116.RAVtPnbjwttz2fgfB3VnEtie_kRl6Jj8o7S-LkB6Wu41A130_assertion wasDerivedFrom befree-20150227 NP331116.RAVtPnbjwttz2fgfB3VnEtie_kRl6Jj8o7S-LkB6Wu41A130_provenance.
- NP331116.RAVtPnbjwttz2fgfB3VnEtie_kRl6Jj8o7S-LkB6Wu41A130_assertion SIO_000772 20499060 NP331116.RAVtPnbjwttz2fgfB3VnEtie_kRl6Jj8o7S-LkB6Wu41A130_provenance.
- NP331116.RAVtPnbjwttz2fgfB3VnEtie_kRl6Jj8o7S-LkB6Wu41A130_assertion evidence source_evidence_literature NP331116.RAVtPnbjwttz2fgfB3VnEtie_kRl6Jj8o7S-LkB6Wu41A130_provenance.
- NP331116.RAVtPnbjwttz2fgfB3VnEtie_kRl6Jj8o7S-LkB6Wu41A130_assertion description "[These preliminary findings suggest that antibody induction to TARP may represent a possible biomarker for treatment response to GM-CSF secreting cellular immunotherapy in prostate cancer patients and demonstrates the utility of using protein microarrays for the high-throughput screening of patient-derived antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331116.RAVtPnbjwttz2fgfB3VnEtie_kRl6Jj8o7S-LkB6Wu41A130_provenance.